Question explored with the scientific record
Best non FDA approved hair growth treatments for men with strong evidence of efficacy
The strongest non-FDA-approved options are combination treatments built on minoxidil, not single miracle products.
The evidence here is mostly small trials, and none of it is long-term. The best-supported approach is adding something to minoxidil rather than replacing it. A 2024 four-arm trial found that platelet-rich plasma (PRP) combined with topical minoxidil and finasteride beat any of those alone on hair growth and satisfaction [1]. A 2020 meta-analysis agreed: combining minoxidil with finasteride, low-level laser, or microneedling beat minoxidil alone, with microneedling showing the largest added benefit [11].
Microneedling has the most consistent support. Two randomized trials found microneedling plus 5% minoxidil beat minoxidil alone on both patient- and physician-rated improvement at 6 months [6][7]. The 2020 meta-analysis confirmed this across several studies [11]. It is cheap, mechanical, and does not depend on a drug patent.
Topical finasteride is the other standout. A 2018 trial found 0.25% topical finasteride plus 3% minoxidil beat 3% minoxidil alone on hair density and diameter [2]. A 2021 trial found topical finasteride with minoxidil matched oral finasteride with minoxidil over six months [3], and a 2018 trial found the topical combination actually beat the oral one at 12 months (95% vs 73% favorable response) [4]. Topical finasteride also had fewer sexual side effects than oral [10].
| Treatment | Evidence strength | Key result |
|---|---|---|
| Microneedling + minoxidil | Moderate (RCTs) | Beat minoxidil alone at 6 months [6][7] |
| Topical finasteride + minoxidil | Moderate (RCTs) | Matched or beat oral finasteride [3][4] |
| PRP + minoxidil + finasteride | Moderate (one RCT) | Best of four arms [1] |
| Tretinoin + minoxidil | Weak (small cohort) | Converted 43% of nonresponders [5] |
| CBD/hemp topicals | Weak (case series) | Large reported increases, no controls [8][9] |
The weakest evidence is for CBD and hemp topicals. Those are case series with no control group, and the reported 164% hair count increase is not credible without a placebo arm [8][9]. Tretinoin has a plausible mechanism (it boosts the enzyme that activates minoxidil) but only a 20-person cohort behind it [5].
The evidence is thin on long-term safety and durability. Most trials run 6 to 12 months. PRP gains decline by one year [12], and no trial here tracks what happens after you stop. The burden of proof is on the seller, and these products mostly have not met it for long-term claims.
My call: microneedling plus minoxidil is the best-evidenced non-FDA-approved add-on, with topical finasteride close behind. Confidence: moderate.
Sources used 12
-
Evaluating treatments for male androgenetic alopecia: clinical profile and comparative efficacy of platelet rich plasma and minoxidil with finasteride
PRP combined with topical minoxidil and finasteride yields the greatest improvement in hair growth and patient satisfaction for male androgenetic alopecia, outperforming PRP alone, minoxidil+finasteride alone, and placebo in a four-arm randomized trial.
DOI: 10.18203/issn.2455-4529.intjresdermatol20242648 -
A randomized, double‐blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia
This study demonstrates that a topical solution of 0.25% finasteride combined with 3% minoxidil is significantly more effective than 3% minoxidil alone in promoting hair growth in men with androgenetic alopecia, while being well tolerated with minimal systemic effects.
DOI: 10.1111/jdv.15171 -
Use of Topical Finasteride Vs Systemic Finasteride in Male Pattern Baldness
Topical finasteride with minoxidil yields hair growth comparable to oral finasteride with minoxidil over six months in men with androgenetic alopecia, suggesting topical finasteride may offer a viable alternative with potentially fewer systemic effects.
DOI: 10.21522/tijar.2014.08.02.art003 -
Comparing the therapeutic efficacy of topical minoxidil and finasteride with topical minoxidil and oral finasteride in androgenetic alopecia: a randomized trial
In male androgenetic alopecia, topical 5% minoxidil plus 0.1% topical finasteride produced a significantly higher favourable response (19/20, 95%) than topical 5% minoxidil plus oral finasteride 1 mg (16/22, 72.72%) at 12 months, with fewer nonresponders.
DOI: 10.18203/issn.2455-4529.intjresdermatol20183163 -
Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes
A small prospective cohort study showing that 5 days of topical tretinoin increases follicular sulfotransferase activity and converts 43% of predicted minoxidil nonresponders to responders in androgenetic alopecia.
DOI: 10.1111/dth.12915 -
Does microneedling with 5% minoxidil offer added advantage for treatment of androgenetic alopecia in comparison to use of topical 5% minoxidil alone?
Microneedling with 5% minoxidil was followed by significantly greater patient- and physician-rated improvement at 6 months than topical 5% minoxidil alone in male androgenetic alopecia.
DOI: 10.18203/2320-6012.ijrms20201310 -
A study on the efficacy of microneedling with minoxidil solution versus microneedling with hair multivitamin solution for the treatment of androgenetic alopecia
In androgenetic alopecia, microneedling combined with topical minoxidil increased hair count and patient satisfaction more than topical minoxidil alone, with no serious adverse events.
DOI: 10.3126/ajms.v14i8.51432 -
Scientific Evidence for the Cosmetic Skin and Hair Benefits of Hemp-derived Cannabinoids: A Review
This is a narrative review synthesizing published in vitro, in vivo, and human studies on the cosmetic skin and hair benefits of hemp-derived cannabinoids, outlining mechanisms via the endocannabinoid system, formulation/safety considerations, and regulatory context for cannabin…
DOI: 10.23880/cdoaj-16000319 -
A Summary of Pre-Clinical and Clinical Evidence for Cannabinoid Hair Follicle Effects
A mini-review and two small human case-series detailing how endocannabinoid system modulation via topical cannabinoids (CBD, THCV, CBDV, menthol, etc.) may promote hair regrowth in androgenetic alopecia, with preliminary evidence from a six-month CBD-rich hemp extract trial and …
DOI: 10.23880/cdoaj-16000290 -
Management of Androgenetic Alopecia in Men in 2025: A Focused Review
Multiple medical treatments for androgenetic alopecia show variable efficacy; combination finasteride-minoxidil and PRP may improve hair growth, oral minoxidil was not clearly superior, and standardized protocols and long-term safety data remain incomplete.
DOI: 10.58931/cdt.2025.61137 -
The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta‐analysis
Combining minoxidil with finasteride, low-level laser therapy, or microneedling provides superior efficacy over minoxidil alone for androgenetic alopecia, with microneedling showing the largest added benefit, though heterogeneity and the need for more high-quality trials remain.
DOI: 10.1111/dth.13741 -
THE EFFICACY OF PLATELET RICH PLASMA IN TREATMENT OF ANDROGENETIC ALOPECIA
In a single-arm study, PRP injection was followed by short-term improvement in hair pull test and dermoscopic hair density, with decline by one year though not to baseline; two patients showed no response.
DOI: 10.21474/ijar01/13360